Streetbeat News

Stock Prices

EIS

ISRA

SPY

USO

The article discusses Israeli Prime Minister Netanyahu's decision to wait for the outcome of the U.S. presidential election before committing to a diplomatic path. This decision could impact geopolitical relations and market sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 4:46 pm

CRH

Richard Saperstein announced on CNBC that he has purchased shares of CRH, a company that may be listed on a US exchange. This announcement could influence investor sentiment and potentially impact the stock price of CRH in the short term.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 4:46 pm

VEV

Vicinity Motor Corp shares are trading lower following the resignation of all members of its board of directors.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 4:46 pm

TOST

Josh Brown announced on CNBC that he has purchased shares of Toast, Inc. This public disclosure could influence investor sentiment and potentially impact the stock price of Toast, Inc. in the short term.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 4:45 pm

V

Visa's short interest has decreased by 5.71%, with 22.09 million shares sold short, representing 1.32% of its float. This is lower than its peers' average short interest of 5.55%. The decrease in short interest may indicate a more bullish sentiment towards Visa.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 4:45 pm

CTRE

CareTrust REIT (NYSE:CTRE) has seen a 24.93% decrease in its short percent of float, now at 2.74%. This indicates a more bullish sentiment compared to its peers, which have an average short interest of 7.28%.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 4:45 pm

HIG

Hartford Financial Services Group (NYSE:HIG) has seen a 3.03% decrease in its short interest, with 3.25 million shares sold short, representing 1.28% of its float. This is lower than the peer group average of 1.80%. The decrease in short interest may indicate a more bullish sentiment among investors.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 4:45 pm

MRK

MRNA

Moderna and Merck have initiated a Phase 3 trial for V940 (mRNA-4157) in combination with Keytruda for non-small cell lung cancer patients. This follows promising results from earlier trials, leading to a rise in Moderna's stock price.

Portfolio Pulse from Vandana Singh

October 28, 2024 | 4:45 pm

UNCY

Unicycive Therapeutics shares rose following the announcement of poster presentations for Oxylanthanum Carbonate and UNI-494 at the American Society of Nephrology Kidney Week 2024.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 4:44 pm

MAXN

Maxeon Solar Technologies shares rose following the announcement of changes to its CFO position.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 4:41 pm